for boils

Only to be prescribed for adults having insulin administered by a third party such as District Nursing teams and Care home staff.

Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues. This statement does not cover the use of tirzepatide for managing overweight and obesity. NICE are currently developing separate guidance for its use in these conditions.

Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues. This statement does not cover the use of tirzepatide for managing overweight and obesity. NICE are currently developing separate guidance for its use in these conditions.

Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues. This statement does not cover the use of tirzepatide for managing overweight and obesity. NICE are currently developing separate guidance for its use in these conditions.

Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues. This statement does not cover the use of tirzepatide for managing overweight and obesity. NICE are currently developing separate guidance for its use in these conditions.

Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues. This statement does not cover the use of tirzepatide for managing overweight and obesity. NICE are currently developing separate guidance for its use in these conditions.

Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues. This statement does not cover the use of tirzepatide for managing overweight and obesity. NICE are currently developing separate guidance for its use in these conditions.

Available to order Free of Charge from Alliance Healthcare 2023/2024 Where treatment with both Paxlovid and sotrovimab are both contraindicated or not clinically suitable AND treatment with remdesivir is contraindicated, not clinically suitable or not available, as per NHSE policy

For use only in adult patients with moderate to severe persistent facial erythema associated with rosacea. It is not indicated for symptoms of flushing and GPs may wish to consider seeking dermatology advice (eg email communication) prior to prescribing to ensure appropriate use. Its use is contraindicated in patients receiving monoamine oxidase inhibitor therapy or tricyclic or tetracyclic antidepressants

Used as a weekly dose only

Unlicensed Special

Licensed only for adults for the treatment of excessive sleepiness associated with narcolepsy with or without cataplexy.

Vitamin deficiencies are common in patients with renal disease due to dietary restrictions, changes to metabolism and vitamin loss during dialysis. Renavit® should only be initiated by a renal dietician- ongoing prescribing in primary care is acceptable.

Monopost eye drops (latanoprost unit dose vials) are accepted for use in patients who have proven sensitivity to the preservative benzalkonium chloride and should be used in preference to tafluprost. Monopost is substantially more expensive than the equivalent generic multi-dose eye drop preparation with preservative.

Licensed only for adults for the treatment of excessive sleepiness associated with narcolepsy with or without cataplexy.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

Cost-effective alternative to liquid preparations, where tablets cannot be crushed and dissolved. Please note use is off-label for children under 6 years.

Treatment of insomnia in children and adolescents aged 2 to 18 years with autism spectrum disorder and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.

Buccolam is the preferred formulation in the SCG for community paediatrics. CFT LD team also use Buccolam but may also use Epistatus occasionally in selected patients. Please note the difference in concentration between brands.

Naloxegol is recommended in accordance with NICE TA345 (July 2015) for the treatment of opioid induced constipation in adults whose constipation has not adequately responded to laxatives.

Naloxegol is recommended in accordance with NICE TA345 (July 2015) for the treatment of opioid induced constipation in adults whose constipation has not adequately responded to laxatives.

Treatment of insomnia in children and adolescents aged 2 to 18 years with autism spectrum disorder and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.